Search

everythinglearnresearchcommunity

for

Search:↓

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Vitamin supplements may not improve hair thickness or density in patients with non-scarring hair loss.

Lower 2D:4D finger ratios in HS patients suggest prenatal hormone influence on the disease.

Subclinical hypothyroidism in women with PCOS affects thyroid and hormone interactions but not ovary structure.

Prescription and alternative therapies for hair loss will be compared for effectiveness.

Methotrexate is best for lichen planopilaris, and retinoids are best for frontal fibrosing alopecia, but side effects are common.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Many people with inflammatory bowel disease have a vitamin C deficiency, which can lead to scurvy symptoms.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Vitamin D levels are not correlated with chronic hair loss in Telogen Effluvium patients.

PRP injections are safe for hair loss treatment, but monitoring and sun protection are advised.

Long-term, low-dose finasteride may reduce the risk of benign prostatic hyperplasia and prostate cancer.

Reporter characteristics affect detection of hair loss from cancer therapy.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

Robotic technology in plastic surgery shows promise but needs more research and cost reduction for wider use.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

Rituximab improved her dermatomyositis better than usual treatments.

The albumin change rate helps predict treatment success in AIDS-related non-Hodgkin lymphoma.

High chromogranin A levels are linked to obesity and inflammation in polycystic ovary syndrome.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

GLP-1 agonists may help treat certain skin conditions.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

SPIOMET therapy may be a promising alternative to oral contraceptives for treating adolescent PCOS.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

The study has limitations, and future research should use better methods to improve treatment for children with hair loss.

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

More skin lesions in lupus patients may indicate higher disease activity.